TruthArchive.ai - Related Video Feed

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

Some batches of the vaccine may have serious side effects or be degraded. The batch number can be checked to see what to expect. Documentation shows that certain batches have more serious adverse effects. Even the best batches from Pfizer and Moderna had a high rate of serious adverse events in the short term, around 1800.

A recent study involving 99 million COVID vaccine recipients found increased risks of neurological and heart disorders, described as rare but significant. For example, the risk of brain swelling increased by 378%, myocarditis by 610%, and Guillain Barre syndrome by 286%. The cumulative risk of these adverse events raises questions about the overall safety of vaccines, especially considering the CDC's childhood vaccination schedule, which includes 72 doses without long-term safety trials. Each vaccine has a list of potential side effects, many serious, yet they are often labeled as rare. Historical data shows a rise in chronic illnesses among vaccinated children, suggesting a troubling trend. The notion that vaccine injuries are non-existent is misleading, as many children are experiencing adverse effects. It’s crucial to recognize and evaluate these risks comprehensively.

Vaccines must be carefully studied to ensure they do not worsen infections. Past vaccines, like the respiratory syncytial virus vaccine for children, have unexpectedly made things worse. Similarly, an HIV vaccine increased infection risk in some cases. It's crucial to conduct thorough studies in high-risk populations to understand how vaccines truly impact infections before widespread use.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

In some cases, vaccines can have an unintended effect called enhancement. This has been observed with certain vaccines like dengue and respiratory syncytial virus. When these vaccines don't provide a strong immune response and a person is later exposed to the disease, it can actually worsen the symptoms. This is a concern that we want to avoid.

No successful coronavirus vaccine has been made. Gene-based vaccines were tested on animals, leading to sickness and death. Despite concerns about safety and lack of long-term data, Canada continued vaccine rollout. A doctor raised safety concerns, was reprimanded for causing vaccine hesitancy, and saw neurological issues in patients post-vaccination. Questions to health authorities went unanswered, leading to a complaint to the College of Physicians and Surgeons.

A new study published in Frontiers in Medicine reveals that COVID-19 vaccination may double the risk of post-COVID death after one year. The research analyzed over 15,000 severe acute respiratory syndrome cases in Brazil from 2020 to 2023, finding that while vaccination initially reduced mortality risk, this effect reversed long-term. The study recorded 5,157 deaths, with higher risks among older adults and those with less education. The authors suggest that the initial protective effect could be linked to healthier behaviors among vaccinated individuals, while long-term risks may arise from vaccine-related adverse effects. The findings call for further investigation into these trends, emphasizing the need for reevaluation of vaccination policies. The discussion also highlights the broader implications for public health and the urgent need for accountability regarding vaccine safety.

Vaccines are crucial for saving lives, including those for smallpox and measles. However, the COVID vaccine has presented some challenges. Patients who received the vaccine and later contracted COVID experienced more cardiovascular complications. Additionally, booster shots caused severe vasculitic reactions, and it is unclear whether this is due to the vaccine being injected directly into the vein or if it is a result of the patient's antibodies reacting to the booster. Investigations are ongoing, and it is important to provide patients with informed choices regarding this situation. We are in need of further research and guidance to address these concerns.

Monash University has just received a grant from Moderna to produce 100,000,000 doses of messenger RNA vaccine. The speaker questions what arms they are going to go into, and what they are going to have tagged, and what message they will have. They note that Monash has just come out with the RSV data. The speaker recalls a lesson from the 1970s: you steer away from trying to produce an RSV vaccine because you get immune enhanced disease. Many should have told them this; they didn’t cancel things, they put it on pause. So they paused, putting RSV messenger RNA into the arms of infants. The speaker states that twelve point five percent, one in eight, of these kids nearly died from overwhelming RSV infection. Twelve point five percent. The speaker suggests it’s a bit like they can’t control the dose and they shouldn’t have been doing it in the first place.

Two years ago, most people would have refused gene or cell therapy, but the pandemic has changed perceptions of innovation. The COVID vaccine is not a traditional vaccine as it doesn't provide immunity or prevent transmission. The Pfizer vaccine wasn't tested for transmission prevention before its release due to the urgency. Vaccinated individuals can still get COVID-19. Countries with rapid mass vaccination have seen increased infections and deaths. A study from the Cleveland Clinic suggests that the more shots received, the higher the risk of getting COVID. Vaccination puts evolutionary pressure on the virus, leading to mutations. Epidemiological analysis shows a significant number of deaths related to the vaccines, with dangerous mechanisms of action and consistency with other fatal conditions. Temporal relation is also evident, with many deaths occurring shortly after vaccination.

The transcript argues that more dangerous SARS-CoV-2 variants could arise by creating biological niches for variants and through VADES, with the speaker stating that “viral immune escape threatens to play a catastrophic role in the COVID mass vaccinated world.” It describes the virus as originally relatively harmless with a very low death percentage for healthy young people, potentially evolving into a seasonal virus with an even lower death percentage. However, it is claimed that mass vaccination could disturb this natural progression and cause resistant, and potentially more dangerous and more contagious variants by creating biological niches for those variants. The speaker asserts a correlation between the rise of variants and the increase of vaccinations, stating that “the rise of variants correlates with the increase of vaccinations.” In this context, viral immune escape is mentioned, and antibody-dependent enhancement (ADE) is noted as a phenomenon that can worsen disease; the speaker notes that ADE is known to be an issue with coronaviruses and was an issue in animal trials for SARS vaccines, and is associated with SARS and severe COVID itself. The claim is made that as more vaccines and different vaccine types are administered, and as more COVID variants succeed, the ADE risk increases. According to the speaker, given these considerations, the worldwide mass vaccination agenda is described as a “haste and rush agenda,” very dangerous and destined to become a failure. The speaker questions whether “the mass vaccination induced immune escape COVID killing waves and vades” are coming for the COVID vaccinated. To illustrate the situation, the transcript cites a series of record-high stretcher occupancy values in Quebec, across several dates in 2024: 07/08/2024 – 2,319; 07/08/2024 – 2,370; 08/06/2024 – 2,384; 08/27/2024 – 2,395; 08/24/24 – 2,412; 09/03/2024 – 2,444. The source cited is Sourcetumia.org, with a request to “please like and follow.”

The transcript presents a critical examination of Bill Gates, portraying him as transforming from a software magnate into a global health power broker whose wealth and influence have reshaped public health, vaccine development, and population policy. It argues that Gates’ philanthropic activities are not purely charitable but are deployed to extend control over health systems, global research agendas, and even the reproductive choices of people worldwide. Key claims and points are detailed across several strands: - Public image and power shift: Bill Gates is described as no longer a “public health expert” yet becoming a central figure in billions of lives, guiding medical actions and vaccine strategies. The program asserts that Gates’ reinvention through the Bill and Melinda Gates Foundation has been aided by a sophisticated public relations apparatus and by directing media coverage of global health issues. - Foundation scale and reach: The Gates Foundation is depicted as the world’s largest private foundation, with assets reported as tens of billions of dollars and a broad remit in global health, development, growth, and policy advocacy. Its influence extends to funding media outlets, think tanks, and reporting units across multiple outlets (BBC, NPR, Our World in Data, ABC, among others), creating what the program calls “tentacles” across global health. - Partnerships and funding of global health initiatives: Gates is credited with initiating and funding major global health vehicles, including: - Gavi, the Vaccine Alliance, with seed funding and ongoing commitments that have shaped vaccination markets. - The Global Fund to Fight AIDS, Tuberculosis, and Malaria, and other public-private partnerships that coordinate vaccine development and immunization programs. - Support for CEPI (Coalition for Epidemic Preparedness Innovations), the World Health Organization’s vaccine initiatives, and other pandemic preparedness efforts. - The World Health Organization’s funding profile, described as heavily dependent on Gates Foundation support, with Tedros Adhanom Ghebreyesus noted as a non-medical doctor connected to Gates-backed initiatives. - The “Decade of Vaccines” and vaccine policy: Gates is credited with launching a decade-long vaccine initiative, including a pledge of billions of dollars to vaccine development and distribution. This is linked to the creation of a global vaccine action plan and to Gavi’s role in establishing vaccine markets. The narrative asserts that vaccines have been used to steer global health policy and to secure roles for private firms in public health decision-making. - Vaccine development concerns: The program raises concerns about the safety and speed of vaccine development, criticizing the eighteen-month timeline Gates advocates for a universal vaccine, and questioning the use of new technologies (DNA and mRNA platforms) and rapid deployment with limited testing. It highlights potential safety risks, including historical vaccine-associated disease enhancement and concerns about broad immunization in a short period. - Vaccine safety and regulation: It is claimed that vaccine safety at scale is hard to guarantee and that liability protections for vaccine makers and public health officials have been enacted (e.g., a U.S. declaration granting liability immunity for COVID-19 countermeasures), a point framed as enabling risk-bearing without accountability. - Population control framing: A central thread is the assertion that Gates seeks to reduce population growth through health improvements, vaccines, and reproductive health services. The transcript traces Gates’ interest in contraception and population issues to his family background and to Rockefeller-era eugenics historical contexts, arguing that discussions about fertility, contraceptive technologies, and demographic trends have long-term population implications. It cites specific Gates Foundation activities in reproductive health, including funding for innovative birth-control delivery methods, depot injections, implanted devices, and efforts to develop digital identity tied to health services as tools within a broader population-control framework. - Digital identity and biometric ID: The narrative emphasizes Gates’ involvement with biometric identification through Gavi and ID2020, noting partnerships with Microsoft and the Rockefeller Foundation, the Aadhaar system in India, and the World Bank’s ID4D initiative. It argues that vaccination programs, biometric identity, and cashless payments are being integrated into a comprehensive “population control grid,” enabling state and private actors to track, truncate, or deny access to services based on identity and health status. - Data, surveillance, and privacy concerns: The piece contends that the push for digital IDs, digital health records, and biometrics will erode privacy and enable broad government and corporate surveillance, linking health data to financial services, voting, housing, and welfare. It highlights projects involving digital certificates, immunity passports, and real-time health data collection via microneedle patches and barcode-like skin markers, suggesting these innovations could be used to control access to services. - Epstein connections and broader conspiracy context: The program references alleged connections between Gates and Jeffrey Epstein, including flight logs and involvement in philanthropic funding discussions, framing these ties as part of a broader pattern of influence. It also points to prior associations with notable figures (Buffett, Rockefeller, Soros) and critiques of Gates as aligning with a “population control” ideology. - The underlying motive and conclusion: Throughout, the narrative asserts that Gates’ wealth is being used not for charity alone but to build an overarching system of control—over health institutions, research funding, public policy, identification, and financial systems. It contrasts his public image as a generous philanthropist with alleged hidden agendas, suggesting that the real aim is to shape global governance and human behavior through vaccination, identification, and digital infrastructure. - Final framing and call to action: The closing sections urge viewers to recognize Gates’ influence as part of an ideology rather than a single person’s plan. It frames the situation as a broader movement that could continue beyond Gates personally, urging awareness and action to resist what the program deems a population-control regime embedded in global health and digital identity initiatives. In sum, the transcript portrays Bill Gates as a central figure driving a multifaceted, globally interconnected program—through the Gates Foundation, Gavi, CEPI, and related partnerships—that allegedly reconfigures vaccine policy, global health governance, reproductive health, biometric identification, and digital payments into a cohesive system of population control and surveillance, using philanthropy as a veneer for power and control.

The speaker argues that an irrational, unbridled enthusiasm for new possibilities leads to a sacrifice of safety. This enthusiasm, in their view, has adversely affected precautionary considerations and risk assessment. They reference presenting autopsy findings related to deaths following COVID-19 vaccination at the American Society of Microbiology, an event attended by thousands of microbiologists, vaccinologists, and immunologists. In conversations with attendees, the speaker was surprised by what they describe as a scientific seduction surrounding messenger RNA technology. The core concern expressed is that this eagerness to embrace mRNA platforms is accompanied by a neglect of safety considerations. The speaker asserts that there will be a cataclysmic recognition that messenger RNA technology represents an unsafe platform. They emphasize that, as they understand it, there is no way to break down certain aspects of the technology they refer to as “pseudourogenated messenger RNA,” noting this within the context of their work in research laboratories. The statement implies a belief that the degradation or metabolic processing of this form of RNA poses unresolved issues. A central, striking claim presented is that circulating messenger RNA from Pfizer or Moderna has been found in their patients’ bloodstream three years after vaccination, and that this RNA is intact. The speaker underscores this as evidence tied to their observations and research experiences, asserting the persistence of the RNA in the circulatory system over an extended period. Overall, the message conveys a perspective that rapid adoption and optimism around mRNA vaccines and technologies have overshadowed safety considerations, and it anticipates a future realization of safety concerns associated with these platforms. The speaker ties their warnings to concrete experiences at a major scientific conference and to specific, long-term biomarkers observed in patients, presenting a narrative of ongoing research findings and anticipated paradigm shifts in how the safety of mRNA vaccines is perceived.

A peer-reviewed paper confirms Pfizer's mRNA vaccine is contaminated with DNA and SV40 enhancers, considered dangerous. Pfizer used bacterial plasma DNA during mass production, leading to contamination with spike protein genes, antibiotic resistance markers, and SV40 enhancers. Researchers found 4-5 times more DNA than the safe limit. The DNA fragments could integrate into the human genome due to the SV40 enhancer. Injected vaccine samples caused super strong kidney cells to produce spike protein, excreted via exosomes, potentially spreading body-wide. The vaccines were toxic to these cells, causing pathological changes. The DNA, tucked into lipid nanoparticles, could integrate into the human genome, turning the jab into accidental gene therapy. The SV40 enhancer drags DNA into the nucleus. The study suggests the inclusion of SV40 enhancers was deliberate, not accidental, and scrubbed from regulatory paperwork. Experts theorize this contamination could be linked to an explosion of turbo cancers. The study concludes mRNA shots should be suspended until safety is determined. Another study found vaccine spike protein expressed in cerebral arteries of stroke patients for up to 17 months, accompanied by an autoimmune response.

Recent studies have raised serious concerns about the COVID-19 vaccines, particularly regarding potential shedding effects. A new study published in the International Journal of Vaccine Theory found that women indirectly exposed to vaccinated individuals reported significant menstrual irregularities, with over 70% experiencing symptoms shortly after exposure. Additionally, research confirmed the presence of residual DNA in vaccine vials, which could pose risks, including potential integration into human DNA, leading to health issues like cancer. Reports also indicate that heart conditions in vaccinated individuals are worsening over time. Accusations have emerged against Pfizer for allegedly concealing deaths during vaccine trials. These findings highlight the urgent need for further investigation into the safety and long-term effects of COVID-19 vaccines.

Vaccines can sometimes have unexpected effects. In some cases, vaccinating someone against a disease can actually make them more susceptible to the infection. This has happened before with vaccines like the respiratory syncytial virus vaccine in children and an HIV vaccine that was tested a few years ago. So, it's important to carefully evaluate the safety of vaccines before administering them.

There are concerns that the COVID-19 vaccines may have a potential link to cancer. The spike protein in the vaccines could inhibit tumor suppressor systems in the body. Additionally, the vaccines may impair natural DNA repair mechanisms, increasing the risk of DNA damage. Contamination has also been found in Pfizer vials, which could lead to a direct DNA injection and activation of cancer-related genes. This multi-hit hypothesis suggests that repeated vaccination could promote cancer development. There have been clinical observations of rapid cancer progression and reactivation of cancers in remission after vaccination. However, no agency has confirmed a direct link between vaccines and cancer.

There have been reports suggesting a significant increase in cancer rates since the vaccination rollout, with many anecdotal cases emerging globally. The immune system plays a crucial role in identifying and eliminating early cancer cells. However, the vaccination may have impacted immune function, potentially allowing cancers to grow unchecked. The extent of this issue remains unclear, but there are concerns that it could lead to a surge in cancer and other conditions linked to the vaccination program. Notably, some healthcare professionals, like Dr. Ryan Cole in Idaho, have reported increased cancer activity, raising alarms about the lack of thorough studies typically associated with vaccine development, which usually spans 5 to 10 years. This situation is unprecedented and warrants serious attention.

Many people have received COVID shots for various reasons, but there are significant concerns regarding their safety. Reports indicate rising cases of autoimmune diseases, heart inflammation, and neurological issues, including cancer. The lipid nanoparticle mRNA technology used in these vaccines has not proven to be safe long-term. Studies show these shots can suppress the immune system, particularly affecting T cells, which are crucial for fighting infections and cancer. This immune suppression may contribute to the emergence of more aggressive cancers, termed "turbo cancers," as observed by pathologists. Data from insurance and disability datasets reveal alarming increases in cancer cases following the vaccine rollout, raising serious concerns about public health.

Many countries lack proper safety monitoring systems for vaccines, leading to miscommunication and confusion. Adjuvants are necessary for vaccine effectiveness, but can increase adverse reactions. Long-term effects and cross-reactivity between adjuvants are concerns. Health professionals are starting to question vaccine safety due to lack of confidence and education.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The safety of messenger RNA (mRNA) vaccines, such as Pfizer and Moderna, is being questioned. Studies have shown that mRNA can be toxic to heart muscle cells and can remain in the human heart, bloodstream, lymph nodes, and injection site for extended periods. This raises concerns about the safety of mRNA technology for vaccines, as it may make flu shots and other vaccines more dangerous. Some argue for a ban on mRNA development due to the COVID-19 vaccine controversy.

Repeated vaccinations can weaken the immune system by building tolerance and shifting protection away from viruses and cancer. This antigen exposure from vaccines can lead to a loss of protection against other viruses and cancer. It is important to note that there has never been a vaccine that requires people to take it every six months indefinitely, which raises concerns.

We observed potential safety issues with coronavirus vaccines similar to past respiratory virus vaccines. In the 1960s, some children had adverse reactions, even deaths, due to immune enhancement when exposed to the virus after vaccination. This led to the abandonment of the RSV vaccine program for decades. The same immune pathology was seen in laboratory animals during coronavirus vaccine development, raising concerns about safety.